Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia

The application of haploidentical hematopoietic stem cell transplantation (HSCT) with mesenchymal stem cell (MSC) infusion as a treatment regimen for severe aplastic anemia (SAA) has been reported to be efficacious in single-arm trials. However, it is difficult to assess without comparing the result...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zenghui, Wu, Xiaoxiong, Wang, Shunqing, Xia, Linghui, Xiao, Haowen, Li, Yonghua, Li, Hongbo, Zhang, Yuping, Xu, Duorong, Nie, Danian, Lai, Yongrong, Wu, Bingyi, Lin, Dongjun, Du, Xin, Jiang, Zujun, Gao, Yang, Gu, Xuekui, Xiao, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605036/
https://www.ncbi.nlm.nih.gov/pubmed/33194162
http://dx.doi.org/10.1177/2040620720965411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605036/
https://www.ncbi.nlm.nih.gov/pubmed/33194162
http://dx.doi.org/10.1177/2040620720965411

Ejemplares similares